Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP588852.RAlw0olE2hH6oqo2Lck0iQFi-VvD9Ev8P97ASav4QrXd4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP588852.RAlw0olE2hH6oqo2Lck0iQFi-VvD9Ev8P97ASav4QrXd4130_assertion type Assertion NP588852.RAlw0olE2hH6oqo2Lck0iQFi-VvD9Ev8P97ASav4QrXd4130_head.
- NP588852.RAlw0olE2hH6oqo2Lck0iQFi-VvD9Ev8P97ASav4QrXd4130_assertion description "[This demonstrates that NFATc3 is required for SFRP2 induced tube formation, and tacrolimus inhibits angiogenesis in vitro and breast carcinoma growth in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588852.RAlw0olE2hH6oqo2Lck0iQFi-VvD9Ev8P97ASav4QrXd4130_provenance.
- NP588852.RAlw0olE2hH6oqo2Lck0iQFi-VvD9Ev8P97ASav4QrXd4130_assertion evidence source_evidence_literature NP588852.RAlw0olE2hH6oqo2Lck0iQFi-VvD9Ev8P97ASav4QrXd4130_provenance.
- NP588852.RAlw0olE2hH6oqo2Lck0iQFi-VvD9Ev8P97ASav4QrXd4130_assertion SIO_000772 21673995 NP588852.RAlw0olE2hH6oqo2Lck0iQFi-VvD9Ev8P97ASav4QrXd4130_provenance.
- NP588852.RAlw0olE2hH6oqo2Lck0iQFi-VvD9Ev8P97ASav4QrXd4130_assertion wasDerivedFrom befree-20150227 NP588852.RAlw0olE2hH6oqo2Lck0iQFi-VvD9Ev8P97ASav4QrXd4130_provenance.
- NP588852.RAlw0olE2hH6oqo2Lck0iQFi-VvD9Ev8P97ASav4QrXd4130_assertion wasGeneratedBy ECO_0000203 NP588852.RAlw0olE2hH6oqo2Lck0iQFi-VvD9Ev8P97ASav4QrXd4130_provenance.